When price reduction cards may help reduce the load of high drug expenses from the short-term, they do not handle the systemic concerns driving up prescription charges from the U.S. Broader coverage improvements could tackle the foundation results in of increasing drug costs, including not enough transparency in pricing as well as the role of inter